EBGLYSS is an FDA-approved drug for treating moderate-to-severe eczema by targeting IL-13, offering relief to patients ...

Eczema, also known as atopic dermatitis, is a chronic skin condition that affects people of all skin types. Here's what you ...

When people think of sexually transmitted diseases (STDs), they often picture younger people. However, the reality is that ...

The Food and Drug Administration had recently approved a new drug for the treatment of atopic dermatitis (eczema), which can ...

Like you know something isn’t right with your health, but the doctor either dismissed your concerns or prescribed a ...

According to the NHS, eczema is a common skin condition that causes dry and itchy rashes. Currently, in the UK around 1.5 million adults have ... "homoeopathic eczema treatment" have risen by ...

In studies, people saw significant skin clearance in as little as four weeks and meaningful itch relief ... a biologic treatment for adults and children ages 12 years and older.

Feeling a little itchy? Here's how to recognize the most commonly undiagnosed skin irritations, including the one you may ...

Treatment typically ... is a chronic skin condition that causes multiple, itchy bumps on the skin. Estimates suggest that as many as 72 people in every 100,000 adults may get prurigo nodularis ...

The FDA has already approved Zoryve cream (0.3% and 0.15%) for plaque psoriasis and atopic dermatitis in adults and children ...

Friday, the FDA approved Eli Lilly And Co’s (NYSE:LLY) Ebglyss (lebrikizumab-lbkz), a targeted IL-13 inhibitor, for adults and children 12 years of age and older who weigh at least 88 pounds (40 ...

The dermatitis may also cause burning and pain along with itching. In some cases, treatment may be as simple as avoiding the allergen and rubbing or cooling skin instead of scratching it.